GTBP News and Press, GT Biopharma Inc. From 03/29/21

GT Biopharma's TriKE™ Interim Clinical Trial Results Presented At Innate Killer Summit 2021 Outlines the Clinical Power of Immune Engagement with IL-15 Containing TriKEs PR Newswire BEVERLY HILLS, Calif. , March 29, 2021 /PRNewswire/ -- GT Biopharma, I...

4 Biotech Penny Stocks For You End Of March Watch List Whether you’re a big fan of penny stocks or you’re trying to avoid them at all costs, there’s no denying the potential they have. There are very few things you can invest your money in and see quick & large ...

When it comes to penny stocks, you can’t count out volatility. Price plays a big role, and based on the definition of these stocks, even 50 cents can mean big shifts in position value. If you’re new to these cheap stocks, you may not know what I’m talking about. The d...

Are These On The Top Of Your Penny Stocks Watch List Right Now? I get it; certain penny stocks are seeing some pressure. However, with as many that are under fire, there are plenty of others that have weathered the latest market volatility like pros. What’s been the differences? ...

Biotech Penny Stocks Catching Attention From Robinhood Traders Should you buy penny stocks this week? It has become one of the hottest trends in the stock market today. These low-priced stocks continue creating a buzz among retail traders of all backgrounds. If 2020 taught us one thing,...

4 Penny Stocks to Watch as Stimulus Checks Roll In Markets were mixed at the open this morning, but it’s been a more bullish trend for penny stocks. In this case, let’s take a look at the Russell 2000 Small-Cap ETF ( NYSE: IWM ). As you’ll see, in tandem with ot...

Penny Stocks To Watch This Month When it comes to finding penny stocks to buy , you can look at things like industry events, corporate filings, and of course, headlines. With this, you’ve also got to consider other things going on in the market. For instance, even if an energ...

GT Biopharma (GTBP) announces updated interim Phase I/II clinical trial results for the company's lead therapeutic candidate, GTB-3550, being evaluated for the treatment of high-risk myelodysplastic syndromes ((MDS)) and refractory/relapsed acute myeloid leukemia ((AML)).Patients enrolled ear...

A day after the U.S. Federal Trade Commission signaled more scrutiny over what was considered as ‘anti-competitive’ mergers in the pharmaceutical industry, Citi analysts have weighed in on its impact on big pharma’s growth ambitions.The analysts Andrew Baum and ...

GT Biopharma Announces Updated Interim GTB-3550 Trike™ Clinical Trial Results Up to 63.7% Reduction in Bone Marrow Blast Levels Restores Patient's Endogenous NK Cell Function, Proliferation and Immune Surveillance No Progenitor-derived or Autologous/Allogenic Cell...